What's New
Front Page
AFTD and Denali Therapeutics Discuss Takeda Pharmaceuticals Partnership to Develop FTD-Focused Therapeutic
Recently, members of the Denali Therapeutics team provided insights into their work and partnership with Takeda to…
Study Evaluates the Feasibility of ALLFTD’s Mobile App to Collect FTD Diagnostic Data
A study published in the journal Alzheimer’s and Dementia evaluates whether a mobile app developed by the…
STAT Article Explores the Connection Between FTD and Visual Creativity
An article published by STAT explores the connection between the onset of FTD and a spike in…
Advocacy Update: AFTD Ambassadors Offer Insights at July NAPA Meeting
At the most recent meeting of the National Alzheimer’s Project Act (NAPA) Advisory Council, AFTD Ambassadors Katie Zenger and Terry…
Recent CBS Report Discusses Link between FTD and Creativity with Dr. Bruce Miller
A report recently aired by KPIX in San Francisco highlights the spike in creativity that has been…
Wall Street Journal Article Shares Story of Doctor’s Five Years of FTD Uncertainty
An article published in the Wall Street Journal shares the difficult journey former gynecologist Dr. Seth L….
Help & Support: Genetic Testing and DNA Banking
The decision to undergo genetic testing for FTD is deeply personal. Many want to know their genetic…
The Lived Experience of FTD: Tracking Changing Behaviors in FTD
For people living with an FTD diagnosis and their care partners, keeping track of the changing behaviors…
One-Night Performance of Acclaimed Play UnRavelled Examines Art, Science, and Dementia
AFTD staff and Board members attended a performance of the play UnRavelled at the San Francisco Conservatory…
New York Times Magazine Chronicles a Family Living with the Threat of Genetic FTD
The cover story of the July 23 issue of the New York Times Magazine chronicles the experiences…
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)